INeuplatňuje se.nclude information on physical and chemical incompatibilities of the medicinal product with other products with which it is likely to be mixed or co-administered. This is particularly important for medicinal products to be reconstituted and/or diluted before parenteral administration. Significant interaction problems, eg, sorption of products or product components to syringes, large volume parenteral containers, tubing, administration sets, etc, should be stated.
Statements concerning compatibility of the product with other medicinal products or devices should be included not in this section but in Section 6.6. Statements concerning pharmacologic incompatibilities with food should be included in the Section 4.5.
Where studies have not been carried out, and if appropriate for the product, a warning should be included not to mix the product with other medicinal products.
If incompatibilities are not appropriate for the product (eg, solid oral pharmaceutical forms) use the statement ‘not applicable’:
(cs)